Clinical Research Directory
Browse clinical research sites, groups, and studies.
Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen
Sponsor: Institut Paoli-Calmettes
Summary
This study is an extension to younger patients of the currently ongoing national, multicenter, open-label, randomized phase III HAPLOMUDELDERLY which evaluates elderly patients with hematological malignancies, justifying an allo-HSCT from an alternative donor when a MRD has not been identified. It will extend the investigation of these two modalities of allo-HSCT to younger patients which are eligible to RIC.
Official title: Extension of a Phase III Randomized Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen-HaploMUD-RIC-01
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
9
Start Date
2017-09-19
Completion Date
2021-03-12
Last Updated
2026-10-01
Healthy Volunteers
No
Interventions
Hematopoietic stem cells transplantation
Allogeneic Hematopoietic stem cells transplantation
Locations (1)
Institut Paoli-Calmettes
Marseille, France